TopGum Acquires Island Abbey Nutritionals

Brenntag Specialties Acquires Colony Gums

October 9, 2023

Food & Beverage

Brenntag Specialties, the life-sciences division of Brenntag SE, has acquired Colony Gums, Inc., a family‑owned Monroe, North Carolina manufacturer of stabilizer systems and hydrocolloids. The deal will give Colony access to Brenntag’s global distribution network while strengthening Brenntag’s position in the nutrition and specialty ingredients market through Colony’s formulation expertise.

Benford Capital Partners Recapitalizes Gum Products International

August 16, 2022

Food & Beverage

Chicago-based private equity firm Benford Capital Partners recapitalized Gum Products International (GPI), a Newmarket, Ontario-based food ingredients manufacturer, as the first platform investment from its Fund II. BCP will partner with founder and CEO Kenneth Tan to invest in sales, R&D and pursue add-on acquisitions focused on hydrocolloids, antimicrobials and other functional powdered ingredients to drive organic growth.

TPG Growth Takes Majority Stake in SmartSweets

October 27, 2020

Food & Beverage

TPG Growth has taken a majority stake in SmartSweets, the Vancouver-based better-for-you candy brand founded by Tara Bosch. Bosch remains the largest individual shareholder and will stay on the board while Douglas MacFarlane joins as CEO; financial terms were not disclosed. The investment is intended to accelerate SmartSweets' growth, distribution expansion, and product innovation.

TPG Capital to Acquire Majority Stake in Diocle Topco S.àr.l., Parent of DOC Generici

June 30, 2022

Pharmaceuticals

TPG Capital has signed a definitive agreement to acquire a majority interest in Diocle Topco S.àr.l., the parent company of DOC Generici, from ICG and Mérieux Equity Partners. DOC Generici is a leading Italian manufacturer of generic pharmaceuticals based in Milan; TPG said it will partner with management to pursue organic and inorganic growth in the Italian generics market.

TPG Growth Acquires Implantable Provider Group (IPG)

April 20, 2021

Healthcare Services

TPG Growth, the middle-market and growth equity platform of TPG, has acquired Implantable Provider Group, Inc. (IPG), a provider of surgical cost management solutions. The transaction represents an exit for Camden Partners (and acknowledges prior investor Sequoia Capital) and positions IPG to accelerate geographic expansion and scale its surgical cost-management and analytics platform.

Gum Products International (Benford Capital) Acquires International Protein Colloids

November 29, 2023

Food & Beverage

Benford Capital Partners’ portfolio company Gum Products International has completed an add-on acquisition of International Protein Colloids, a Venus, Texas-based manufacturer of proprietary gelatin and protein blends for pet treat and pet food customers. The deal will expand GPI’s product portfolio and presence in the pet end market; IPC will continue operating from its current location under President David Walsh.